Published online Apr 16, 2022. doi: 10.12998/wjcc.v10.i11.3587
Peer-review started: December 1, 2021
First decision: January 22, 2022
Revised: February 7, 2022
Accepted: February 27, 2022
Article in press: February 27, 2022
Published online: April 16, 2022
Processing time: 127 Days and 21.3 Hours
The incidence of cervical pregnancy is increasing due to the recent widespread application of assisted reproductive technology. Although hysterectomy has been a treatment option, high-sensitivity human chorionic gonadotropin testing and improved accuracy of transvaginal ultrasound imaging have increased possibility of uterine preservation. Dilation and curettage with methotrexate therapy and uterine artery embolization have been reported as treatments with fertility preservation; however, certain disadvantages limit their use.
In our two reported cases, we avoided massive bleeding and immediately resumed infertility treatment using ultrasound-guided local ethanol injection for cervical pregnancies with fetal heartbeats.
This treatment may be a new fertility-preserving option for cervical pregnancy.
Core Tip: We describe the use of transvaginal ultrasound-guided local injection of absolute ethanol as a new treatment method for cervical pregnancy that preserves fertility. In both cases, the patients had developed cervical pregnancy through assisted reproductive technology and sought fertility-preserving treatment. A local injection of absolute ethanol allowed resumption of menstruation 2 mo after treatment and early resumption of infertility treatment without any complications. We suggest that local injection of absolute ethanol for cervical pregnancy could be a safe and effective new treatment method.